Welcome to LookChem.com Sign In|Join Free
  • or
4-[2-(1H-imidazol-1-yl)ethoxy]benzaldehyde is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

205371-43-3

Post Buying Request

205371-43-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

205371-43-3 Usage

Structure

It is a benzaldehyde derivative with an ethoxy linker connecting to a 1H-imidazole group.

Application

Organic Synthesis: Used in organic chemistry for the creation of various compounds.
Pharmaceutical Research: Employed in the study of potential biological activities and drug development.

Biological Activity

Antifungal Properties: Reported to exhibit antifungal effects.
Antimicrobial Properties: Demonstrates antimicrobial activity.

Versatility

Chemical: Useful in various chemical reactions and syntheses.
Pharmaceutical: Potential applications in drug development and research.

Implications

Chemistry: Versatile compound for diverse chemical reactions.
Pharmaceuticals: Potential for the development of new drugs.
Biotechnology: Study of imidazole-containing compounds and their applications.

Potential Uses

Industrial Applications: Utilized in industrial processes.
Medical Applications: Potential for medical treatments due to its properties.

Overall Significance

Versatile compound with implications in chemistry, pharmaceuticals, and biotechnology.

Check Digit Verification of cas no

The CAS Registry Mumber 205371-43-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,5,3,7 and 1 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 205371-43:
(8*2)+(7*0)+(6*5)+(5*3)+(4*7)+(3*1)+(2*4)+(1*3)=103
103 % 10 = 3
So 205371-43-3 is a valid CAS Registry Number.
InChI:InChI=1/C12H12N2O2/c15-9-11-1-3-12(4-2-11)16-8-7-14-6-5-13-10-14/h1-6,9-10H,7-8H2

205371-43-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(2-imidazol-1-ylethoxy)benzaldehyde

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:205371-43-3 SDS

205371-43-3Downstream Products

205371-43-3Relevant academic research and scientific papers

Generation of catalytic amphiphiles in a self-reproducing giant vesicle

Sheng, Li,Kurihara, Kensuke

supporting information, p. 598 - 600 (2016/07/06)

Giant vesicles capable of generating a catalytic amphiphile that promoted vesicular membrane production were prepared. The catalyst was derived from decylaniline on the vesicles and a catalytic aldehyde present outside the vesicles. Once the catalyst was

Synthesis, antimalarial activity and cytotoxic potential of new monocarbonyl analogues of curcumin

Manohar, Sunny,Khan, Shabana I.,Kandi, Shamseer Kulangara,Raj, Kranthi,Sun, Guojing,Yang, Xiaochuan,Calderon Molina, Angie D.,Ni, Nanting,Wang, Binghe,Rawat, Diwan S.

supporting information, p. 112 - 116 (2013/02/23)

A series of novel monocarbonyl analogues of curcumin have been designed, synthesized and tested for their activity against Molt4, HeLa, PC3, DU145 and KB cancer cell lines. Six of the analogues showed potent cytotoxicity towards these cell lines with IC50 values below 1 μM, which is better than doxorubicin, a US FDA approved drug. Several analogues were also found to be active against both CQ-resistant (W2 clone) and CQ-sensitive (D6) strains of Plasmodium falciparum in an in-vitro antimalarial screening. This level of activity warrants further investigation of the compounds for development as anticancer and antimalarial agents.

SUBSTITUTED 1-AMINOPHTHALAZINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC APPLICATION THEREOF

-

Page/Page column 66-67, (2009/05/28)

The invention concerns 1-amino-phthalazine derivatives of general formula (I): Wherein A, B, L, R, R1, R2, R3, R4, R5 and R7 are as defined herein. The invention also concerns the preparation of said compounds and their therapeutic use.

Novel euglycemic and hypolipidemic agents

Lohray, Braj B.,Bhushan, Vidya,Rao, Bheema P.,Madhavan, Gurram R.,Murali, Nagabelli,Rao, Krowidi N.,Reddy, Ananth K.,Rajesh, Bagepalli M.,Reddy, Pamulapati G.,Chakrabarti, Ranjan,Vikramadithyan, Reeba K.,Rajagopalan, Ramanujam,Mamidi, Rao N.V.S.,Jajoo, Hemant K.,Subramaniam, Swaminathan

, p. 1619 - 1630 (2007/10/03)

A series of [[(heterocyclyl)ethoxy]benzyl]-2,4-thiazolidinediones have been synthesized by the condensation of corresponding aldehyde 1 and 2,4- thiazolidinedione followed by hydrogenation. Both unsaturated thiazolidinedione 2 and its saturated counterpar

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 205371-43-3